Synthesis, Characterization, and in vivo Distribution of Intracellular Delivered Macrolide Short‐Chain Fatty Acid Derivatives

Abstract

Short-chain fatty acids (SCFAs) have a range of effects in metabolism and immune regulation. We have observed that delivery of SCFAs to lysosomes has potent immune regulatory effects, possibly as a surrogate signal for the presence of anaerobic organisms. To better understand the pharmacology of lysosomal SCFA donors, we investigated the distribution and metabolism of propionate and butyrate donors. Each analog (1 a and 2 a) can donate three SCFA equivalents via ester hydrolysis through six intermediate metabolites. The compounds are stabilized by low pH, and stability in cells is usually higher than in medium, but is cell-type specific. Butyrate derivatives were found to be more stable than propionates. Triesters were more stable than di-or mono-esters. The donors were surprisingly stable in vivo, and hydrolysis of each position was organ specific. Jejunum and liver caused rapid loss of 4'' esters. The gut metabolite pattern by i. v. differed from that of p.o. application, suggesting luminal and apical enzyme effects in the gut epithelium. Central organs could de-esterify the 11position. Levels in lung relative to other organs were higher by p.o. than via i. v., suggesting that delivery route can influence the observed pharmacology and that gut metabolites distribute differently. The donors were largely eliminated by 24 h, following near linear decline in organs. The observed levels and distribution were found to be consistent with pharmacodynamic effects, particularly in the gut.

Immune cell targeted fumaric esters support a role of GPR109A as a primary target of monomethyl fumarate in vivo

“…uptake of Azithromycin into immune cells [25] which we confirmed in a previous study demonstrating beneficial distribution patterns (spleen, liver and lung) for anti-inflammatory effect after oral application [28]. Although some previous studies showed a possible effect of Azithromycin in psoriasis, our focus was on understanding the efficacy of fumarates.…”

“…and organs collected 2 and 4 h after treatment. Collected samples stored at -25 °C until further processing, as published [28].…”

The Azithromycin Pro-Drug CSY5669 Boosts Bacterial Killing While Attenuating Lung Inflammation Associated with Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus

“…CSY5669 and its metabolites were quantified using liquid chromatography coupled to a triple quadrupole MSMS detector (API 4500, Sciex, Canada) as described previously ( 45 ). Briefly, samples were homogenized in 6 volumes of acetonitrile, and the resulting supernatant was separated via reverse phase chromatography followed by mass-specific detection.…”

Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease models

“…Frozen organ samples were thawed and treated as described earlier [20]. Briefly, samples were digested with Proteinase K in a buffer volume in µL corresponding to sample weight in mg (Proteinase K, VWR, diluted 1:40 in phosphate buffer 20 mM) for 1 h at 50 °C and homogenized at 6 m/s for 40 s (FastPrep-24 5G, MP Biomedicals).…”